表紙
市場調査レポート

医療用途向けナノテクノロジー (ナノメディシン) の世界市場

Nanotechnology in Medical Applications: The Global Market

発行 BCC Research 商品コード 229027
出版日 ページ情報 英文 156 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
医療用途向けナノテクノロジー (ナノメディシン) の世界市場 Nanotechnology in Medical Applications: The Global Market
出版日: 2015年09月24日 ページ情報: 英文 156 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

医療用ナノテクノロジー、すなわちナノメディシンの世界市場は2014年には2483億米ドルに達しました。この市場はさらに成長を続ける見通しで、2019年まで16.3%のCAGR (年平均成長率) を維持し、2019年には市場規模が5280億米ドルに到達すると予測されます。

当レポートは、医療用ナノテクノロジー (ナノメディシン) の世界市場を取り上げ、ナノメディシンを支える重要技術について精査し、ナノメディシン市場の特質、構造、市場成長促進要因の分析、また製品カテゴリー別ならびに地域別の市場分析を行い、今後5年間市場予測を示しています。さらにこの市場の主要企業について、最近の企業吸収合併の状況分析を含め、詳細な企業ブロファイルを提供しています。

第1章 序論

第2章 論旨

  • ナノメディシンの定義
  • 研究開発および商用化
  • 用途
  • 市場

第3章 概要

  • ナノテクノロジーについて
  • 広範なナノテクノロジー応用範囲
    • 医療用途
    • 環境応用
    • 軍用
    • 化粧品
    • 開発中の用途
  • ナノテクノロジーのツール
    • C60/フラーレン
    • カーボン・ナノチューブ
    • ナノ粒子
    • ナノワイヤ
    • 分子ナノテクノロジー
  • ナノテクノロジーのリスク
    • 毒性
  • 市場におけるナノテクノロジー
    • 医療用ナノテクノロジー - ナノメディシン
    • 将来の可能性
    • 市場の将来性

第4章 ナノメディシン

  • ナノ医療技術の発展
  • リポソーム
  • デンドリマー

第5章 ナノメディシンの治療応用

  • がん診断および治療
    • シリカナノ粒子
    • ナノスケール・ヒドロゲルシェル
    • 薬剤送達
    • 感染制御

第6章 診断ツール

  • ツール類の実際的応用
    • 各種ツールの開発企業
    • 各種の治療対象技術

第7章 将来動向および研究開発の可能性

  • 非侵襲的ナノデバイス
  • 細胞外デバイス
  • 細胞内デバイス
  • 組織の治癒再生を制御するナノマシン
  • ウィルス除去
  • 修復化学
  • 新臓器および四肢
  • 基本的ナノテクノロジー研究
    • 米国
    • 欧州
    • 日本
  • リスク要因

第8章 ナノメディシン市場

  • 市場成長促進要因
  • 主な製品カテゴリー
    • 薬剤送達
    • 分子診断
    • 臨床応用別市場分析
  • 地域市場分析
    • 米国
    • 日本
    • 欧州

第9章 主要企業プロファイル

  • 世界のナノメディシン業界を構成する主要企業

第10章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC069C

REPORT HIGHLIGHTS

Global nanomedicine market was valued at $214.2 billion in 2013 and $248.3 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 16.3% from 2014 through 2019 and reach $528 billion by 2019.

This report provides:

  • An overview of the global markets for nanotechnology used in medical applications.
  • Analyses of global market trends, with data from 2012 to 2014, and projections of CAGRs through 2019.
  • A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications.
  • Information on a number of significant products in which the nano dimension has made a significant contribution to product effectiveness.
  • A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine.
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.

SCOPE OF REPORT

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and as analyzed by selected national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

ANALYST'S CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the nanomedicine marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • MARKET ANALYSES AND FORECASTS
  • METHODOLOGY
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • DEFINITION OF NANOMEDICINE
  • RESEARCH AND COMMERCIALIZATION
  • APPLICATIONS
    • DRUG DELIVERY
    • DRUGS AND THERAPY
    • IN VIVO IMAGING
    • IN VITRO DIAGNOSTICS
    • BIOMATERIALS
    • ACTIVE IMPLANTS
  • MARKET
    • SUMMARY TABLE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, THROUGH 2019 ($ BILLIONS)
    • SUMMARY FIGURE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, 2012-2019 ($ BILLIONS)

CHAPTER 3 - OVERVIEW

  • ABOUT NANOTECHNOLOGY
  • THE MANY USES OF NANOTECHNOLOGY
    • MEDICAL APPLICATIONS
    • ENVIRONMENTAL APPLICATIONS
    • MILITARY APPLICATIONS
    • COSMETICS
    • APPLICATIONS IN DEVELOPMENT
  • THE TOOLS OF NANOTECHNOLOGY
    • C60/FULLERENES
    • CARBON NANOTUBES
    • NANOPARTICLES
    • NANOWIRES
    • MOLECULAR NANOTECHNOLOGY
  • RISKS OF NANOTECHNOLOGY
    • POISON/TOXICITY
  • NANOTECHNOLOGY IN THE MARKETPLACE
    • MEDICAL NANOTECHNOLOGY - NANOMEDICINE
    • FUTURE POSSIBILITIES
    • MARKET POTENTIAL

CHAPTER 4 - NANOMEDICINE

  • DEVELOPMENT OF NANOMEDICAL TECHNOLOGIES
    • TABLE 1: NANOMEDICINE -- ESTMIATED TIMESCALE BY DECADE
    • TABLE 2: MAIN NANOTECHNOLOGIES AND APPLICATIONS IN MEDICINE
  • LIPOSOMES
    • TABLE 3: MARKETED LIPOSOMAL NANOPHARMACEUTICAL PRODUCTS
  • DENDRIMERS
    • NANOCRYSTALS
      • TABLE 4: MARKETED NANOCRYSTAL PHARMACEUTICAL PRODUCTS
    • MICELLES
      • TABLE 5: MARKETED PRODUCTS IN MICELLE FORM
    • FULLERENES
    • POLYMERIC NANOPARTICLES
    • NANOPARTICLE-DRUG CONJUGATES
    • LIGAND-TARGETED NANOPARTICLES
    • CERAMIC NANOPARTICLES
    • VIROSOME NANOPARTICLES

CHAPTER 5 - THERAPEUTIC USES OF NANOMEDICINE

  • CANCER DIAGNOSTICS AND THERAPY
    • SILICA NANOSPHERES
    • NANOSCALE HYDROGEL SHELLS
      • Carbon Nanoparticles
      • Photodynamic Therapy and Gold
      • Dendrimer Conjugates
      • Ligand-Targeted Emulsion Technologies
      • Linear Cyclodextrin-Containing Polymers
      • Smart Lipid-Based Nanocarriers
      • Thermotherapy Using Magnetic Nanoparticles
      • Targeted Cell Destruction
      • Nanoshells
    • DRUG DELIVERY
      • TABLE 6: MARKETED PRODUCTS WITH NANO-ENHANCED DRUG DELIVERY
      • AlphaRx
      • Aphios
      • Bind Biosciences
      • Biodelivery Sciences
      • Calando Pharmaceuticals Inc.
      • Capsulution NanoScience
      • Ceramisphere
      • CytImmune
      • Health Plus International
      • IGI Laboratories Inc.
      • Labopharm
      • MagnaMedics
      • Mebiopharm
      • Nanocopoeia
      • NanoCrystal
      • NanoMed
      • NanoCyte
      • NanoPharm
      • Nanotherapeutics
      • Nanotrope
      • pSivida
      • Selecta Biosciences
      • SoluBest
      • Transave/Insmed
    • INFECTION CONTROL
      • Silver Nanoparticles against Infection
      • Detecting Nanobacteria
      • Killing Viruses

CHAPTER 6 - DIAGNOSTIC TOOLS

  • PRACTICAL APPLICATION OF TOOLS
    • COMPANIES THAT DEVELOP THE TOOLS
      • BioCrystal/InVitrogen
      • BioForce
      • Biophage
      • CombiMatrix
      • Farfield Sensors
      • GE Healthcare BioSciences
      • Immunicon
      • MagnaMedics
      • Nanogen
      • Nanosphere
      • Qiagen
      • Sphere
      • TransGenex
      • Veredus
    • VARIOUS THERAPEUTIC TARGETS TECHNOLOGIES
      • Anthrax
      • Cholesterol
      • Artificial Retina
      • Nerve Regeneration
      • Crossing the Blood-Brain Barrier
      • Protecting Against Radiation Damage
      • Antibody Therapeutics
      • Hemostasis
      • Bone Fracture Repair
      • Dental Implant and Tissue Regeneration
      • Vaccine Adjuvant
      • Treatment of Thrombosis
      • Coatings for Stents and Other Devices

CHAPTER 7 - FUTURE TRENDS AND RESEARCH POSSIBILITIES

  • NON-INVASIVE NANODEVICES
  • EXTRACELLULAR DEVICES
  • INTRACELLULAR DEVICES
  • NANOMACHINES TO CONTROL TISSUE HEALING
  • ELIMINATING VIRUSES
  • CORRECTING CHEMISTRY
  • NEW ORGANS AND LIMBS
  • FUNDAMENTAL NANOTECHNOLOGY RESEARCH
    • UNITED STATES
      • University at Albany-SUNY
      • Cornell University
      • University of Michigan
      • Rice University
      • University of Pennsylvania
      • University of Virginia
      • University of North Carolina
      • Ohio State University
      • Northwestern University
      • University of Pittsburgh
      • Case Western Reserve University
      • University of California at Berkeley
    • EUROPE
      • TABLE 7: EUROPEAN NANOCENTRES
    • JAPAN
      • Development of Active Targeting DDS
      • Development of Novel Tissue Engineering
      • Development of New Biomaterials
  • THE RISK FACTOR

CHAPTER 8 - MARKETS FOR NANOMEDICINE

  • TABLE 8: MARKETED NANOPHARMACEUTICALS
  • TABLE 9: MARKETED NANO-IMAGING, DIAGNOSTICS AND BIOMATERIALS
  • MARKET DRIVERS
    • MARKET ESTIMATES AND FORECASTS
      • TABLE 10: GLOBAL MARKET SHARE FOR NANOTECHNOLOGY BY INDUSTRY SECTOR, 2010 (%)
    • GLOBAL NANOMEDICINE MARKET
      • TABLE 11: GLOBAL NANOMEDICINE, NANOPHARMACEUTICAL AND NANODIAGNOSTIC MARKET, THROUGH 2019 ($ BILLIONS/%)
  • MAIN PRODUCT CATEGORIES
    • DRUG DELIVERY
    • MOLECULAR DIAGNOSTICS
    • MARKET ANALYSIS BY CLINICAL APPLICATION
      • Cancer
        • TABLE 12: MAJOR MARKETED ANTICANCER NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALES ($ MILLIONS)
        • TABLE 13: GLOBAL MARKET FOR CANCER NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
      • CNS Disorders
        • TABLE 14: MAJOR MARKETED CNS NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFATURER AND SALES ($ MILLIONS)
        • TABLE 15: GLOBAL MARKET FOR CNS NANOMEDICINES
      • Infection
        • TABLE 16: MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALE ($ MILLIONS)
        • TABLE 17: GLOBAL MARKET FOR ANTI-INFECTIVE NANOMEDICINE, NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
      • Cardiovascular and Autoimmune Disorders
        • TABLE 18: MAJOR MARKETED NANOMEDICINE PRODUCTS FOR CARDIOVASCULAR AND INFLAMMATORY DISEASES BY COMPONENT, MANUFACTURER AND SALE ($ BILLIONS)
        • TABLE 19: GLOBAL MARKET FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY NANOPRODUCTS ($ BILLIONS)
  • REGIONAL MARKET ANALYSIS
    • U.S.
      • TABLE 20: U.S. NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • Japan
      • TABLE 21: JAPANESE NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • Europe
      • TABLE 22: GERMAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 23: FRENCH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 24: UNITED KINGDOM NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 25: ITALIAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 26: BELGIUM AND NETHERLANDS NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 27: SPANISH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)

CHAPTER 9 - COMPANY PROFILES

  • COMPANIES THAT COMPRISE THE GLOBALNANOMEDICINE INDUSTRY
    • ABLYNX NV
    • ABRAXIS BIOSCIENCE INC.
    • ACRYMED INC.
    • ACUSPHERE INC.
    • AMAG PHARMACEUTICALS INC.
    • ALLTRACELL
    • ANSON NANO-BIOTECHNOLOGY
    • APHIOS CORP.
      • Protein Nanoparticles
      • Polymer Nanospheres
      • Phospholipid Nanosomes
    • BIND THERAPEUTICS INC.
    • BIOCRYSTAL LTD.
    • BIOFORCE NANOSCIENCES INC.
      • The ViriChip Virus Detection Platform
    • BIO-GATE AG
      • Medical Applications
    • BIOPHAGE PHARMA INC.
      • BioPhage Products
      • Development through Collaborations:
      • Phages
    • BIOPHAN TECHNOLOGIES INC.
    • CALANDO PHARMACEUTICALS INC.
      • About CALAA-01
    • C SIXTY INC.
    • COMBIMATRIX CORP.
      • Drug Development
    • ELAN DRUG TECHNOLOGIES
    • FARFIELD SCIENTIFIC
    • GE HEALTHCARE
    • IGI LABORATORIES INC.
    • KEREOS INC.
      • KER-1001
      • KER-1002
      • KER-1003
    • KEYSTONE NANO INC.
      • NanoJackets
    • KLEINDIEK NANOTECHNIK GMBH
      • NanoWorkstation
    • LABOPHARM INC.
    • LIPLASOME PHARMA A/S
    • LUMERA CORP.
      • Product Portfolio
      • Nanocapture Microarrays
    • MAGFORCE NANOTECHNOLOGIES AG
    • MAGNAMEDICS GMBH
      • Diagnostics:
      • Efficient and Low-Cost Diagnostics
      • Multifunctional Drug Carrier
    • MICROFLUIDICS INTERNATIONAL CORP.
    • MIDATECH PHARMA PLC
    • MIV THERAPEUTICS INC.
      • Cardiovascular Heart Stents
    • MOLECULAR PROFILES (NOW JUNIPER PHARMACEUTICALS )
    • NANOBAC PHARMACEUTICALS INC.
    • NANOBIO CORP.
    • NANOBIOTIX
    • NANOCARRIER CO. LTD.
    • NANOCOPOEIA INC.
    • NANOCYTE INC.
    • NANOGEN INC.
      • Electronic Microarray
      • Instrumentation
        • Molecular Biology Workstation
        • Molecular Biology Workstation Cartridge
        • NanoChip 400 System
    • NANOLOGIX INC.
    • NANOMED PHARMACEUTICALS INC.
    • NANOMIX INC.
    • NANOSPECTRA BIOSCIENCES INC.
    • NANOSPHERE INC.
    • NANOSTRUCTURES INC.
    • NANOSYN INC.
    • NANOTHERAPEUTICS INC.
    • NANOTROPE INC.
      • Technology
    • NANOVIRICIDES INC.
      • Pipeline
    • NUCRYST PHARMACEUTICALS
    • NUTRALEASE LTD.
    • ORION INTEGRATED BIOSCIENCES INC.
      • Genomic Signatures
      • Rational Antiviral Development
      • Discovery of Malaria Invasion Pathways
    • ORTHOVITA INC.
    • PIONEER SURGICAL TECHNOLOGY
    • PSIVIDA LTD.
    • QIAGEN NV
    • SOLUBEST LTD.
    • STARPHARMA
      • Dendrimer Nanotechnology
    • TECAN GROUP LTD.
    • TRANSGENEX NANOBIOTECH INC.
      • Therapy

CHAPTER 10 - APPENDIX

  • GLOSSARY

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, THROUGH 2019 ($ BILLIONS)
    • TABLE 1: NANOMEDICINE -- ESTMIATED TIMESCALE BY DECADE
    • TABLE 2: MAIN NANOTECHNOLOGIES AND APPLICATIONS IN MEDICINE
    • TABLE 3: MARKETED LIPOSOMAL NANOPHARMACEUTICAL PRODUCTS
    • TABLE 4: MARKETED NANOCRYSTAL PHARMACEUTICAL PRODUCTS
    • TABLE 5: MARKETED PRODUCTS IN MICELLE FORM
    • TABLE 6: MARKETED PRODUCTS WITH NANO-ENHANCED DRUG DELIVERY
    • TABLE 7: EUROPEAN NANOCENTRES
    • TABLE 8: MARKETED NANOPHARMACEUTICALS
    • TABLE 9: MARKETED NANO-IMAGING, DIAGNOSTICS AND BIOMATERIALS
    • TABLE 10: GLOBAL MARKET SHARE FOR NANOTECHNOLOGY BY INDUSTRY SECTOR, 2010 (%)
    • TABLE 11: GLOBAL NANOMEDICINE, NANOPHARMACEUTICAL AND NANODIAGNOSTIC MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 12: MAJOR MARKETED ANTICANCER NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALES ($ MILLIONS)
    • TABLE 13: GLOBAL MARKET FOR CANCER NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
    • TABLE 14: MAJOR MARKETED CNS NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFATURER AND SALES ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR CNS NANOMEDICINES
    • TABLE 16: MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALE ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET FOR ANTI-INFECTIVE NANOMEDICINE, NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
    • TABLE 18: MAJOR MARKETED NANOMEDICINE PRODUCTS FOR CARDIOVASCULAR AND INFLAMMATORY DISEASES BY COMPONENT, MANUFACTURER AND SALE ($ BILLIONS)
    • TABLE 19: GLOBAL MARKET FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY NANOPRODUCTS ($ BILLIONS)
    • TABLE 20: U.S. NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 21: JAPANESE NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 22: GERMAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 23: FRENCH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 24: UNITED KINGDOM NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 25: ITALIAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 26: BELGIUM AND NETHERLANDS NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 27: SPANISH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, 2012-2019 ($ BILLIONS)
Back to Top